Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells

Neoplasia

Volumn 10, Issue 9, 2008, Pages 954-963

  Scheper, Mark A ^a   Shirtliff, Mark E ^a   Meiller, Timothy F ^a   Peters, Brian M ^a   Jabra Rizk, Mary Ann ^a,b  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FARNESOL;

APOPTOSIS; ARTICLE; CANDIDA ALBICANS; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SQUAMOUS CELL CARCINOMA;

EID: 50949114194     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08444     Document Type: Article

References (58)

1. Wright MM and McMaster CR (2002). Phospholipid synthesis, diacylglycerol compartmentation, and apoptosis. Biol Res 35, 223-229.
2. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, Procaccini M, Ferrari F, De Rosa G, and Altieri DC (2003). Survivin expression in oral squamous cell carcinoma. Br J Cancer 89, 2244-2248.
3. Parkin DM, Bray F, Ferlay J, and Pisani P (2005). Global Cancer Statistics, 2002. CA Cancer J Clin 55, 74-108.
4. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, and Nagata S (1998). A caspase-activated Dnase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43-50.
5. Hengartner MO (2001). Apoptosis: DNA destroyers. Nature 412, 2729.
6. Altieri DC (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22, 8581-8589.
7. Scheper MA, Sauk JJ, and Nikitakis NG (2006). COX-independent antimeo-plastic effects of sulindac in oral cancer are mediated by survivin down-regulation. Anticancer Res 26, 4103-4113.
8. Burke YD, Ayoubi AS, Werner SR, McFarland BC, Heilman DK, Ruggeri BA, and Crowell PL (2002). Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. Anticancer Res 22, 3127-3134.
9. Rao CV, Newmark HL, and Reddy BS (2002). Chemopreventive effect of farnesol and lanosterol on colon carcinogenesis. Cancer Detect Prev 26, 419-425.
10. Wiseman DA, Werner SR, and Crowell PL (2007). Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21 (Cipl) and p27(Kip1) in human pancreatic adenocarcinoma cells. J Pharmacol Exp Ther 320, 1163-1170.
11. Voziyan PA, Haug JS, and Melnykovych G (1995). Mechanism of farnesol cytotoxicity: further evidence for the role of PKC-dependent signal transduction in farnesol-induced apoptotic cell death. Biochem Biophys Res Commun 212, 479-486.
12. Edwards PA and Ericsson J (1999). Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Annu Rev Biochem 68, 157-185.
13. Ramage G, Saville SP, Wickes BL, and Lopez-Ribot JL (2002). Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 68, 5459-5463.
14. Sato T, Watanabe T, Mikami T, and Matsumoto T (2004). Farnesol, a morpho-genetic autoregulatory substance in the dimorphic fungus Candida albicans, inhibits hyphae growth through suppression of a mitogen-activated protein kinase cascade. Biol Pharm Bull 27, 751-752.
15. Jabra-Rizk MA, Shirtliff ME, James C, and Meiller TF (2006). Effect of farnesol on fluconazole resistance in Candida dubliniensis. FEMS Yeast Res 6, 1063.
16. Gillum AM, Tsay EY, and Kirsch DR (1984). Isolation of the Candida albicans gene for orotidine'5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198, 179-182.
17. Chen J, He Q, Yuen A, and Chiu J (2004). Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 4, 2465-2475.
18. He Q, Chen J, Kung H, Yuen A, and Chiu J (2004). Identification of tumorassociated proteins in tongue squamous cell carcinoma by proteomics. Proteomics 4, 271-278.
19. Koike H, Uzawa K, Nakashima D, Kato Y, Higo M, Kouzu Y, Endo Y, Kasamatsu A, and Tanzawa H (2005). Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 27, 59-67.
20. Turhani D, Krapfenbauer K, Thurnher D, Langen H, and Fountoulakis M (2006). Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27, 1417-1423.
21. Gorg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, and Weiss W (2000). The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21, 1037-1053.
22. Wang Z, Chen HT, Roa W, and Finlay WH (2003). Farnesol for aerosol inhalation: nebulization and activity against human lung cancer cells. J Pharm Pharm Sci 6, 95-100.
23. Li H, Zhu H, Xu CJ, and Yuan J (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501.
24. Arya R, Mallik M, and Lakhotia SC (2007). Heat shock genes - integrating cell survival and death. J Biosci 32, 595-610.
25. Di Fiore B, Ciciarello M, and Lavia P (2004). Mitotic functions of the Ran GTPase network: the importance of being in the right place at the right time. Cell Cycle 3, 305-313.
26. Frasor J, Chang EC, Komm B, Lin CY, Vega VB, Liu ET, Miller LD, Smeds J, Bergh J, and Katzenellenbogen BS (2006). Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res 66, 7334-7340.
27. Garrido C, Brunet M, Didelot C, Zermati Y, Schmitt E, and Kroemer G (2006). Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 5, 2592-2601.
28. Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, et al. (2007). Differential immunohisto-chemical and biological profile of squamous cell carcinoma of the breast. Anticancer Res 27 (1B), 547-555.
29. Iwakuma T and Lozano G (2003). MDM2, an introduction. Mol Cancer Res 1, 993-1000.
30. Meiers I, Shanks JH, and Bostwick DG (2007). Glutathione S-transferase pi (GSTP1) hypetmethylation in prostate cancer: review 2007. Pathology 39, 299-304.
31. Plotnikoff NP, Faith RE, Mutgo AJ, Herberman RB, and Good RA (1997). Methionine enkephalin: a new cytokine-human studies. Clin Immunol Immunopathol 82, 93-101.
32. Ray DW, Littlewood AC, Clark AJ, Davis JR, and White A (1994). Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function. J Clin Invest 93, 1625-1630.
33. Vartiainen MK and Machesky LM (2004). The WASP-Arp2/3 pathway: genetic insights. Curr Opin Cell Biol 16, 174-181.
34. Wang W, Mouneimne G, Sidani M, Wyckoff J, Chen X, Makris A, Goswami S, Bresnick AR, and Condeelis JS (2006). The activity status of cofilin is directly related to invasion, intravasation, and metastasis of mammary tumors. J Cell Biol 173, 395-404.
35. Boersma HH, Kietselaer BL, Stolk LM, Bennaghmouch A, Hofstra L, Narula J, Heidendal GA, and Reutelingsperger CP (2005). Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med 46, 2035-2050.
36. Boraldi F, Annovi G, Carraro F, Naldini A, Tiozzo R, Sommer P, and Quaglino D (2007). Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach. Biochem Biophys Acta 1774, 1402-1413.
37. Cascante M, Centelles JJ, Veech RL, Lee WN, and Boros LG (2000). Role of thiamin (vitamin B-1) and transketolase in tumor cell proliferation. Nutr Cancer 36, 150-154.
38. Castronovo V (1993). Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 13, 1-30.
39. Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, and Lin KH (2007). Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 7, 155-167.
40. Dear TN and Boehm T (2001). Identification and characterization of two novel calpain large subunit genes. Gene 274, 245-252.
41. Gao B, Sekido Y, Maximov A, Saad M, Forgacs E, Latif F, Wei MH, Lerman M, Lee JH, Perez-Reyes E, Bezprozvanny I, and Minna JD (2000). Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxilliary subunit gene (CACNA2D2). J Biol Chem 275, 12237-12242.
42. Gilmore WS, Olwill S, McGlynn H, and Alexander HD (2004). Annexin A2 expression during cellular differentiation in myeloid cell lines. Biochem Soc Trans 32, 1122-1123.
43. Kondoh H, Lleonart ME, Bernard D, and Gil J (2007). Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. Histol Histopathol 22, 85-90.
44. Rogatsky I, Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq CM, Darimont BD, Garabedian MJ, and Yamamoto KR (2003). Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor. Proc Natl Acad Sci USA 100, 13845-13850.
45. Rupinder SK, Gurpreet AK, and Manjeet SM (2007). Cell suicide and caspases. Vascul Pharmacol 46, 383-393.
46. Shang S, Takai N, Nishida M, Miyazaki T, Nasu K, and Miyakawa I (2003). CaMKIV expression is associated with clinical stage and PCNA-labeling index in endometrial carcinoma. Int J Mol Med 11, 181-186.
47. Tatton WG, Chalmers-Redman RM, Elstner M, Leesch W, Jagodzinski FB, Stupak DP, Sugrue MM, and Tatton NA (2000). Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling. J Neural Transm Suppl 60, 77-100.
48. Zhang B, Zhang Y, Dagher MC, and Shacter E (2005). Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res 65, 6054-6062.
49. Zhang S, Yang JH, Guo CK, and Cai PC (2007). Gene silencing of TKTL1 by RNAi inhibits cell proliferation in human hepatoma cells. Cancer lett 253, 108-114.
50. TAK) and casein kinase 2 in human squamous cell carcinomas and adenocarcinomas of the lung. Cancer Res 54, 2262-2268.
51. Grune T Reinheckel T and Davies KJ (1997). Degradation of oxidized proteins in mammalian cells. FASEB J 11, 526-534.
52. Holland DB, Roberts SG, Wood EJ, and Cunliffe WJ (1993). Cold shock induces the synthesis of stress proteins in human keratinocytes. J Invest Dermatol 101, 196-199.
53. Martin-Zanca D, Hughes SH, and Barbacid M (1986). A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319, 743-748.
54. Muhlhausser P and Kutay U (2007). An in vitro nuclear disassembly system reveals a role for the RanGTPase system and microtubule-dependent steps in nuclear envelope breakdown. J Cell Biol 178, 595-610.
55. Zhou G, Li H, Gong Y, Shao Y, Cheng J, Lee P, and Zhao Y (2005). Proteomic analysis of global alteration of protein expression in squamous cell carcinoma of the esophagus. Proteomics 5, 3814-3821.
56. Dubois T Mira JP, Feliers D, Solito E, Russo-Marie F, and Oudinet JP (1998). Annexin V inhibits protein kinase C activity via a mechanism of phospholipid sequestration. Biochem J 330, 1277-1282.
57. Rautemaa R, Hietanen J, Niissalo S, Pirinen S, and Perheentupa J (2006). Oral and oesophageal squamous cell carcinoma - a complication or component of autoimmune polyendocrinopaty-candidiasis-ectodermal dystrophy (APECED, APS-I0). Oral Oncol 43, 607-613.
58. Rosa DD, Pasqualotto AC, and Denning DW (2007). Chronic mucocutaneous candidiasis and oesophageal cancer. Med Mycol August 28, 1-7.